(Sharecast News) - Diaceutics, a technology and solutions provider catering to the pharmaceutical and biotech industry, announced the appointment of Amie Mc Neice as vice-president of marketing on Tuesday.
The AIM-traded firm said Mc Neice, with a background in senior marketing and business development roles at organisations including Almac Group, Fibrus and Kingspan, would bring extensive leadership experience to her new role.
In her capacity as vice-president of marketing, she would spearhead the execution of Diaceutics' three-year marketing vision, focusing on brand positioning, messaging, and the integration of marketing automation.
Notably, her experience in collaborating with US pharma customers would be instrumental in furthering Diaceutics' market presence.
"I am delighted to welcome Amie to the team at Diaceutics," said chief commercial officer Jillian Beggs.
"Our continued investment in sales and marketing supports our mission to provide the data, technology solutions and insights that enable our pharma and biotech customers revolutionise the commercialisation of their products and ultimately improve patient outcomes."
Aligned with its commitment to expanding sales and marketing capabilities in the US and Europe through 2024, Diaceutics said it was "dedicated" to bolstering its team with top-tier talent.
Additionally, it was continuing to invest in product development, exemplified by the ongoing expansion of its product management team in 2024.
The board said the team would play a pivotal role in executing the company's product roadmap and coordinating various product activities across data, scientific and medical services, engagement solutions, engineering, and marketing.
"I have long admired Diaceutics and look forward to working with the team as we expand our sales and marketing capabilities and serve our customers' needs across the US and Europe," commented Amie Mc Neice.
At 1436 BST, shares in Diaceutics were up 0.03% at 104.03p.
Reporting by Josh White for Sharecast.com.
Diaceutics (DXRX)